Top

Current Geriatrics Reports

Published in:

01-03-2020 | Video-Electroencephalogram | Neurology of Aging (K Marder, Section Editor)

Seizures and Epilepsy in the Elderly: Diagnostic and Treatment Considerations

Authors: Christopher J. Elder, Anil Mendiratta

Published in: Current Geriatrics Reports | Issue 1/2020

Abstract

Purpose of Review

The purpose of this review is to highlight important clinical aspects in diagnosis and management of epilepsy in the elderly and to highlight recent literature and its relevance to current practice.

Recent Findings

Recent studies have shown that elderly patients are under referred for evaluation to epilepsy monitoring units and for epilepsy surgery, which has been demonstrated to be safe and effective in this population.

Summary

The elderly are at increased risk for acute symptomatic seizures and epilepsy. Accurate diagnosis can be challenging in older patients due to limitations in history, atypical symptoms, and medical comorbidities. Inpatient video-EEG monitoring is a valuable tool for the clinician when diagnosis is unclear or patients are unresponsive to medication. Drug resistance rates in the elderly are similar to younger adults with epilepsy, but elderly patients are less likely to be referred for epilepsy monitoring unit admissions and epilepsy surgery, despite evidence of safety and effectiveness.

Trends in aging--United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003/03/21 ed2003. p. 101–4, 6.

Wan H, Goodkind D, Kowal P. An aging world: 2015. U.S. Census Bureau, International Population Reports 2016.

Sander JW, Hart YM, Johnson AL, Shorvon SD. National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet. 1990;336(8726):1267–71. https://doi.org/10.1016/0140-6736(90)92959-l.CrossRefPubMed

Annegers JF, Hauser WA, Lee JR, Rocca WA. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia. 1995;36(4):327–33. https://doi.org/10.1111/j.1528-1157.1995.tb01005.x.CrossRefPubMed

Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993;34(3):453–68. https://doi.org/10.1111/j.1528-1157.1993.tb02586.x.CrossRefPubMed

Mendiratta A, Pedley TA. Seizures and Epilepsy in the Elderly. In: Shorvon S, Pedley TA, editors. The Epilepsies 3. 1st ed. Blue Books of Neurology. Philadelphia: Saunders Elsevier; 2009. p. 177–93.

Kotsopoulos IA, van Merode T, Kessels FG, de Krom MC, Knottnerus JA. Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia. 2002;43(11):1402–9. https://doi.org/10.1046/j.1528-1157.2002.t01-1-26901.x.CrossRefPubMed

Cloyd J, Hauser W, Towne A, Ramsay R, Mattson R, Gilliam F, et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res. 2006;68(Suppl 1):S39–48. https://doi.org/10.1016/j.eplepsyres.2005.07.016.CrossRefPubMed

Sidenvall R, Forsgren L, Blomquist HK, Heijbel J. A community-based prospective incidence study of epileptic seizures in children. Acta Paediatr. 1993;82(1):60–5.CrossRef

10.

Forsgren L, Bucht G, Eriksson S, Bergmark L. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia. 1996;37(3):224–9. https://doi.org/10.1111/j.1528-1157.1996.tb00017.x.CrossRefPubMed

11.

Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O, Hauser WA. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol. 2005;4(10):627–34. https://doi.org/10.1016/s1474-4422(05)70172-1.CrossRefPubMed

12.

de la Court A, Breteler MM, Meinardi H, Hauser WA, Hofman A. Prevalence of epilepsy in the elderly: the Rotterdam study. Epilepsia. 1996;37(2):141–7. https://doi.org/10.1111/j.1528-1157.1996.tb00005.x.CrossRefPubMed

13.

Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia. 1991;32(4):429–45. https://doi.org/10.1111/j.1528-1157.1991.tb04675.x.CrossRefPubMed

14.

Galimberti CA, Magri F, Magnani B, Arbasino C, Cravello L, Marchioni E, et al. Antiepileptic drug use and epileptic seizures in elderly nursing home residents: a survey in the province of Pavia, Northern Italy. Epilepsy Res. 2006;68(1):1–8. https://doi.org/10.1016/j.eplepsyres.2005.09.031.CrossRefPubMed

15.

Garrard J, Harms S, Hardie N, Eberly LE, Nitz N, Bland P, et al. Antiepileptic drug use in nursing home admissions. Ann Neurol. 2003;54(1):75–85. https://doi.org/10.1002/ana.10593.CrossRefPubMed

16.

Schachter SC, Cramer GW, Thompson GD, Chaponis RJ, Mendelson MA, Lawhorne L. An evaluation of antiepileptic drug therapy in nursing facilities. J Am Geriatr Soc. 1998;46(9):1137–41. https://doi.org/10.1111/j.1532-5415.1998.tb06654.x.CrossRefPubMed

17.

Beagle AJ, Darwish SM, Ranasinghe KG, La AL, Karageorgiou E, Vossel KA. Relative incidence of seizures and myoclonus in Alzheimer's disease, dementia with Lewy bodies, and Frontotemporal dementia. J Alzheimers Dis. 2017;60(1):211–23. https://doi.org/10.3233/JAD-170031.CrossRefPubMedPubMedCentral

18.

Hauser WA. Seizure disorders: the changes with age. Epilepsia. 1992;33(Suppl 4):S6–14. https://doi.org/10.1111/j.1528-1157.1992.tb06222.x.CrossRefPubMed

19.

Hauser W. Epidemiology of seizures and epilepsy in the elderly. In: Rowan A, Ramsay R, editors. Seizures and epilepsy in the elderly. Boston: Butterworth-Heineman; 1997.

20.

Loiseau J, Loiseau P, Duche B, Guyot M, Dartigues JF, Aublet B. A survey of epileptic disorders in Southwest France: seizures in elderly patients. Ann Neurol. 1990;27(3):232–7. https://doi.org/10.1002/ana.410270304.CrossRefPubMed

21.

Leppik IE, Birnbaum AK. Epilepsy in the elderly. In: Wyllie E, Cascino GD, Gidal BE, Goodkin HP, editors. Wyllie's treatment of epilepsy. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 458–68.

22.

Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–82. https://doi.org/10.1111/epi.12550.CrossRefPubMed

23.

So EL, Annegers JF, Hauser WA, O'Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology. 1996;46(2):350–5. https://doi.org/10.1212/wnl.46.2.350.CrossRefPubMed

24.

Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Dementia and adult-onset unprovoked seizures. Neurology. 1996;46(3):727–30. https://doi.org/10.1212/wnl.46.3.727.CrossRefPubMed

25.

Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology. 2004;62(5 Suppl 2):S24–9. https://doi.org/10.1212/wnl.62.5_suppl_2.s24.CrossRefPubMed

26.

Kellinghaus C, Loddenkemper T, Dinner DS, Lachhwani D, Luders HO. Seizure semiology in the elderly: a video analysis. Epilepsia. 2004;45(3):263–7. https://doi.org/10.1111/j.0013-9580.2004.29003.x.CrossRefPubMed

27.

Silveira DC, Jehi L, Chapin J, Krishnaiengar S, Novak E, Foldvary-Schaefer N, et al. Seizure semiology and aging. Epilepsy Behav. 2011;20(2):375–7. https://doi.org/10.1016/j.yebeh.2010.12.033.CrossRefPubMed

28.

Drury I, Beydoun A. Interictal epileptiform activity in elderly patients with epilepsy. Electroencephalogr Clin Neurophysiol. 1998;106(4):369–73. https://doi.org/10.1016/s0013-4694(97)00158-2.CrossRefPubMed

29.

Salinsky M, Kanter R, Dasheiff RM. Effectiveness of multiple EEGs in supporting the diagnosis of epilepsy: an operational curve. Epilepsia. 1987;28(4):331–4. https://doi.org/10.1111/j.1528-1157.1987.tb03652.x.CrossRefPubMed

30.

Dash D, Hernandez-Ronquillo L, Moien-Afshari F, Tellez-Zenteno JF. Ambulatory EEG: a cost-effective alternative to inpatient video-EEG in adult patients. Epileptic Disord. 2012;14(3):290–7. https://doi.org/10.1684/epd.2012.0529.CrossRefPubMed

31.

Tolchin B, Lee JW, Pavlova M, Dworetzky BA, Sarkis RA. Diagnostic yield of ambulatory EEGs in the elderly. Clin Neurophysiol. 2017;128(7):1350–3. https://doi.org/10.1016/j.clinph.2017.01.005.CrossRefPubMed

32.

• Shih JJ, Fountain NB, Herman ST, Bagic A, Lado F, Arnold S, et al. Indications and methodology for video-electroencephalographic studies in the epilepsy monitoring unit. Epilepsia. 2018;59(1):27–36. https://doi.org/10.1111/epi.13938. This Critical Review and Invited Commentary outlines the rationale and appropriate indications for video-EEG monitoring in the epilepsy monitoring unit, emphasizing this as the gold standard for the definitive diagnosis of epilepsy and seizure-like episodes.CrossRefPubMed

33.

Spritzer SD, Riordan KC, Berry J, Corbett BM, Gerke JK, Hoerth MT, et al. Fall prevention and bathroom safety in the epilepsy monitoring unit. Epilepsy Behav. 2015;48:75–8. https://doi.org/10.1016/j.yebeh.2015.05.026.CrossRefPubMed

34.

Noe KH, Drazkowski JF. Safety of long-term video-electroencephalographic monitoring for evaluation of epilepsy. Mayo Clin Proc. 2009;84(6):495–500. https://doi.org/10.1016/s0025-6196(11)60580-6.CrossRefPubMedPubMedCentral

35.

Benbadis SR, O'Neill E, Tatum WO, Heriaud L. Outcome of prolonged video-EEG monitoring at a typical referral epilepsy center. Epilepsia. 2004;45(9):1150–3. https://doi.org/10.1111/j.0013-9580.2004.14504.x.CrossRefPubMed

36.

Drury I, Selwa LM, Schuh LA, Kapur J, Varma N, Beydoun A, et al. Value of inpatient diagnostic CCTV-EEG monitoring in the elderly. Epilepsia. 1999;40(8):1100–2. https://doi.org/10.1111/j.1528-1157.1999.tb00825.x.CrossRefPubMed

37.

McBride AE, Shih TT, Hirsch LJ. Video-EEG monitoring in the elderly: a review of 94 patients. Epilepsia. 2002;43(2):165–9. https://doi.org/10.1046/j.1528-1157.2002.24401.x.CrossRefPubMed

38.

Lee SK. Epilepsy in the Elderly: Treatment and Consideration of Comorbid Diseases. J Epilepsy Res. 2019;9(1):27–35. https://doi.org/10.14581/jer.19003.CrossRefPubMedPubMedCentral

39.

Benbadis S. The differential diagnosis of epilepsy: a critical review. Epilepsy Behav. 2009;15(1):15–21. https://doi.org/10.1016/j.yebeh.2009.02.024.CrossRefPubMed

40.

Hogl B, Iranzo A. Rapid Eye Movement Sleep Behavior Disorder and Other Rapid Eye Movement Sleep Parasomnias. Continuum (Minneap Minn). 2017;23(4, Sleep Neurology):1017–34. https://doi.org/10.1212/con.0000000000000489.CrossRef

41.

Brown RJ, Syed TU, Benbadis S, LaFrance WC Jr, Reuber M. Psychogenic nonepileptic seizures. Epilepsy Behav. 2011;22(1):85–93. https://doi.org/10.1016/j.yebeh.2011.02.016.CrossRefPubMed

42.

LaFrance WC Jr, Reuber M, Goldstein LH. Management of psychogenic nonepileptic seizures. Epilepsia. 2013;54(Suppl 1):53–67. https://doi.org/10.1111/epi.12106.CrossRefPubMed

43.

Duncan R, Oto M, Martin E, Pelosi A. Late onset psychogenic nonepileptic attacks. Neurology. 2006;66(11):1644–7. https://doi.org/10.1212/01.wnl.0000223320.94812.7a.CrossRefPubMed

44.

Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. First Seizure Trial Group (FIR.S.T. Group). Neurology. 1993;43(3 Pt 1):478–83. doi:https://doi.org/10.1212/wnl.43.3_part_1.478.CrossRef

45.

Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology. 1991;41(7):965–72. https://doi.org/10.1212/wnl.41.7.965.CrossRefPubMed

46.

Lhatoo SD, Johnson AL, Goodridge DM, MacDonald BK, Sander JW, Shorvon SD. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol. 2001;49(3):336–44.CrossRef

47.

Carlson C, Anderson CT. Special Issues in Epilepsy: The Elderly, the Immunocompromised, and Bone Health. Continuum (Minneap Minn). 2016;22(1 Epilepsy):246–61. https://doi.org/10.1212/con.0000000000000273.CrossRef

48.

Pack AM. Treatment of epilepsy to optimize bone health. Curr Treat Options Neurol. 2011;13(4):346–54. https://doi.org/10.1007/s11940-011-0133-x.CrossRefPubMed

49.

Italiano D, Perucca E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update. Clin Pharmacokinet. 2013;52(8):627–45. https://doi.org/10.1007/s40262-013-0067-4.CrossRefPubMed

50.

Werhahn KJ, Trinka E, Dobesberger J, Unterberger I, Baum P, Deckert-Schmitz M, et al. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Epilepsia. 2015;56(3):450–9. https://doi.org/10.1111/epi.12926.CrossRefPubMed

51.

Werhahn KJ. Epilepsy in the elderly. Dtsch Arztebl Int. 2009;106(9):135–42. https://doi.org/10.3238/arztebl.2009.0135.CrossRefPubMedPubMedCentral

52.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology and the American Epilepsy Society. Neurology. 2018;91(2):74–81. https://doi.org/10.1212/wnl.0000000000005755.CrossRefPubMed

53.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs II: treatment-resistant epilepsy: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of neurology and the American Epilepsy Society. Neurology. 2018;91(2):82–90. https://doi.org/10.1212/wnl.0000000000005756.CrossRefPubMed

54.

Beerhorst K, van der Kruijs SJ, Verschuure P, Tan IY, Aldenkamp AP. Bone disease during chronic antiepileptic drug therapy: general versus specific risk factors. J Neurol Sci. 2013;331(1–2):19–25. https://doi.org/10.1016/j.jns.2013.05.005.CrossRefPubMed

55.

Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine elderly study group. Epilepsy Res. 1999;37(1):81–7. https://doi.org/10.1016/s0920-1211(99)00039-x.CrossRefPubMed

56.

Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology. 2005;64(11):1868–73. https://doi.org/10.1212/01.Wnl.0000167384.68207.3e.CrossRefPubMed

57.

Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342(5):314–9. https://doi.org/10.1056/nejm200002033420503.CrossRefPubMed

58.

Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345(5):311–8. https://doi.org/10.1056/nejm200108023450501.CrossRefPubMed

59.

• Bialek F, Rydenhag B, Flink R, Malmgren K. Outcomes after resective epilepsy surgery in patients over 50 years of age in Sweden 1990–2009--a prospective longitudinal study. Seizure. 2014;23(8):641–5. https://doi.org/10.1016/j.seizure.2014.05.003. This prospective longitudinal study assessed outcomes following resective epilepsy surgery, comparing 67 patients aged ≥ 50 years with 491 patients aged 19–49 years. 61% were seizure free in each group, and major complications were low (3%) in each group.CrossRefPubMed

60.

Grivas A, Schramm J, Kral T, von Lehe M, Helmstaedter C, Elger CE, et al. Surgical treatment for refractory temporal lobe epilepsy in the elderly: seizure outcome and neuropsychological sequels compared with a younger cohort. Epilepsia. 2006;47(8):1364–72. https://doi.org/10.1111/j.1528-1167.2006.00608.x.CrossRefPubMed

61.

Dewar S, Eliashiv D, Walshaw PD, Engel J Jr, Fried I, Moseley BD. Safety, efficacy, and life satisfaction following epilepsy surgery in patients aged 60 years and older. J Neurosurg. 2016;124(4):945–51. https://doi.org/10.3171/2015.3.Jns142317.CrossRefPubMed

62.

Drane DL. MRI-guided stereotactic laser ablation for epilepsy surgery: promising preliminary results for cognitive outcome. Epilepsy Res. 2018;142:170–5. https://doi.org/10.1016/j.eplepsyres.2017.09.016.CrossRefPubMed

63.

• Youngerman BE, Oh JY, Anbarasan D, Billakota S, Casadei CH, Corrigan EK, et al. Laser ablation is effective for temporal lobe epilepsy with and without mesial temporal sclerosis if hippocampal seizure onsets are localized by stereoelectroencephalography. Epilepsia. 2018;59(3):595–606. https://doi.org/10.1111/epi.14004. In this series of 30 patients who underwent mesial temporal laser ablation, 6 patients were ≥ 60 years of age. 4/6 patients were seizure free, comparing favorably with the younger group (12/24 patients were seizure free).CrossRefPubMed

64.

Kang JY, Wu C, Tracy J, Lorenzo M, Evans J, Nei M, et al. Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy. Epilepsia. 2016;57(2):325–34. https://doi.org/10.1111/epi.13284.CrossRefPubMed

65.

Jobst BC, Kapur R, Barkley GL, Bazil CW, Berg MJ, Bergey GK, et al. Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas. Epilepsia. 2017;58(6):1005–14. https://doi.org/10.1111/epi.13739.CrossRefPubMed

66.

Fisher R, Salanova V, Witt T, Worth R, Henry T, Gross R, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia. 2010;51(5):899–908. https://doi.org/10.1111/j.1528-1167.2010.02536.x.CrossRefPubMed

Title: Seizures and Epilepsy in the Elderly: Diagnostic and Treatment Considerations
Authors: Christopher J. Elder
Anil Mendiratta
Publication date: 01-03-2020
Publisher: Springer US
Keywords: Video-Electroencephalogram
Epilepsy
Epileptic Seizure
Published in: Current Geriatrics Reports / Issue 1/2020
Electronic ISSN: 2196-7865
DOI: https://doi.org/10.1007/s13670-020-00310-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com